August 17, 2017 7:50 PM ET

Biotechnology

Company Overview of Kallyope Inc.

Company Overview

Kallyope Inc. develops transformational therapeutics and consumer products in the areas of human health and nutrition. Its biotechnology platform uses technologies in the areas of sequencing, bioinformatics, neural imaging, cellular and molecular biology, and human genetics to provide an understanding of gut-brain axis biology. Kallyope Inc. was incorporated in 2014 and is based in New York, New York.

430 East 29th Street

8th Floor

New York, NY 10016-8367

United States

Founded in 2014

Phone:

312-961-4671

Key Executives for Kallyope Inc.

Chief Executive Officer and Member of the Board of Directors
Co-Founder and Member of the Board of Directors
Senior Vice President of Drug Discovery
Compensation as of Fiscal Year 2017.

Kallyope Inc. Key Developments

Kallyope Inc. Presents at NY/NJ CEO Conference, Nov-02-2016 03:10 PM

Kallyope Inc. Presents at NY/NJ CEO Conference, Nov-02-2016 03:10 PM. Venue: Apella at Alexandria Center, 450 E. 29 Street, New York, NY 10016, United States. Speakers: Nancy Thornberry, Chief Executive Officer and Member of the Board of Directors.

Kallyope Inc. Appoints Management

Kallyope Inc. announced that it has appointed Ann E. Weber, Ph.D. to the position of Senior Vice President, Drug Discovery, and William J. Rieflin as an independent member of its Board of Directors. Dr. Weber will be responsible for taking opportunities arising from the company's technology platform and translating them into drug discovery and development programs.  During her 28-year tenure at Merck & Co., where she was most recently Vice President, Lead Optimization Chemistry, her work led to over 40 development candidates, including the approved diabetes therapies JANUVIA® (sitagliptin), JANUMET® (sitagliptin and metformin), and MARIZEV® (omarigliptin). Mr. Rieflin is Chief Executive Officer of NGM Bio and has over 20 years of experience in the biotechnology industry.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kallyope Inc., please visit www.kallyope.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.